Aethlon Medical (AEMD) Competitors $0.72 -0.01 (-1.65%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$0.72 0.00 (-0.28%) As of 09/5/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEMD vs. BTCY, IINN, DHAI, MHUA, INBS, TNON, LYRA, CODX, XAIR, and OSRHShould you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Biotricity (BTCY), Inspira Technologies OXY B.H.N. (IINN), DIH Holding US (DHAI), Meihua International Medical Technologies (MHUA), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Lyra Therapeutics (LYRA), Co-Diagnostics (CODX), Beyond Air (XAIR), and OSR (OSRH). These companies are all part of the "medical equipment" industry. Aethlon Medical vs. Its Competitors Biotricity Inspira Technologies OXY B.H.N. DIH Holding US Meihua International Medical Technologies Intelligent Bio Solutions Tenon Medical Lyra Therapeutics Co-Diagnostics Beyond Air OSR Aethlon Medical (NASDAQ:AEMD) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends. Which has higher earnings & valuation, AEMD or BTCY? Aethlon Medical has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAethlon Medical$570K3.29-$13.39M-$12.64-0.06Biotricity$12.06M1.42-$14.09M-$0.21-3.29 Do analysts recommend AEMD or BTCY? Aethlon Medical presently has a consensus price target of $56.00, suggesting a potential upside of 7,656.23%. Given Aethlon Medical's higher possible upside, equities analysts clearly believe Aethlon Medical is more favorable than Biotricity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, AEMD or BTCY? Aethlon Medical has a beta of 1.92, meaning that its stock price is 92% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Is AEMD or BTCY more profitable? Aethlon Medical has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Aethlon Medical's return on equity.Company Net Margins Return on Equity Return on Assets Aethlon MedicalN/A -266.21% -179.46% Biotricity -80.42%N/A -188.47% Do insiders & institutionals believe in AEMD or BTCY? 2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 1.2% of Aethlon Medical shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer AEMD or BTCY? In the previous week, Aethlon Medical had 6 more articles in the media than Biotricity. MarketBeat recorded 8 mentions for Aethlon Medical and 2 mentions for Biotricity. Aethlon Medical's average media sentiment score of 0.08 beat Biotricity's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Biotricity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAethlon Medical beats Biotricity on 9 of the 14 factors compared between the two stocks. Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEMD vs. The Competition Export to ExcelMetricAethlon MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.88M$47.74B$5.83B$9.91BDividend YieldN/A77.76%6.70%4.52%P/E Ratio-0.0610.2676.2926.13Price / Sales3.291.05531.70173.48Price / CashN/A8.8436.9959.28Price / Book0.282.3611.486.09Net Income-$13.39M$2.64B$3.29B$266.51M7 Day Performance-61.39%-6.80%1.28%0.45%1 Month Performance-46.12%5.76%8.56%5.05%1 Year Performance-74.04%-35.33%61.19%26.03% Aethlon Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEMDAethlon Medical2.2717 of 5 stars$0.72-1.6%$56.00+7,656.2%-74.0%$1.88M$570K-0.0610News CoverageShort Interest ↑BTCYBiotricityN/A$0.65+23.2%N/A+78.4%$16.27M$12.06M-0.6040Gap UpIINNInspira Technologies OXY B.H.N.2.9285 of 5 stars$1.14-2.6%$2.00+75.4%+11.5%$14.77MN/A0.0020Short Interest ↓Analyst RevisionDHAIDIH Holding US1.0704 of 5 stars$0.28-1.9%N/A-90.4%$13.51M$64.47M-0.93N/ANews CoverageShort Interest ↓Gap DownMHUAMeihua International Medical Technologies1.5653 of 5 stars$0.42+0.6%N/A-64.0%$13.30M$96.90M0.00620Positive NewsShort Interest ↓INBSIntelligent Bio Solutions0.2449 of 5 stars$1.47-0.7%N/A-1.9%$13.29M$3.05M-0.7210Analyst DowngradeTNONTenon Medical1.2075 of 5 stars$1.39-6.7%$5.50+295.7%-69.9%$13.23M$3.28M-0.058News CoverageShort Interest ↑LYRALyra Therapeutics2.3306 of 5 stars$6.92-7.4%$100.00+1,345.1%-49.8%$12.28M$770K-0.2450CODXCo-Diagnostics4.1124 of 5 stars$0.32-0.7%$5.50+1,636.7%-76.9%$12.28M$3.91M-0.28100XAIRBeyond Air4.0958 of 5 stars$2.28+1.3%$11.00+382.5%-73.0%$11.76M$3.70M-0.1970OSRHOSRN/A$1.01+96.1%N/AN/A$11.12MN/A0.00N/AHigh Trading Volume Related Companies and Tools Related Companies BTCY Alternatives IINN Alternatives DHAI Alternatives MHUA Alternatives INBS Alternatives TNON Alternatives LYRA Alternatives CODX Alternatives XAIR Alternatives OSRH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEMD) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
